Table 5 Cytogenetic categories and response to therapy in the cohort of LEN patients
| A. All patient who received LEN for more than 3 months (N = 38) | |||
|---|---|---|---|
| Normal cytogenetic group | Abnormal cytogenetic group | p value | |
| Categorized by MC only | 64% | 33% | 0.07 |
| Categorized by MC/FISH/SNP-A | 64% | 54% | 0.4 |
| B. Monotherapy (LEN only) patients (N = 27) | |||
| Normal cytogenetic group | Abnormal cytogenetic group | p value | |
| Categorized by MC | 60% | 17% | 0.08 |
| only | |||
| Categorized by MC/FISH/SNP-A | 64% | 44% | 0.27 |
| C. Patients with combination therapy of AZA + LEN (N = 11) | |||
| Normal cytogenetic group | Abnormal cytogenetic group | p value | |
| Categorized by MC only | 75% | 67% | 0.85 |
| Categorized by MC/FISH/SNP-A | 67% | 75% | 0.85 |